Good news for breast cancer patients!! FDA has given expanded approval to Herceptin which is a breast cancer drug in order to treat women who underwent surgery. In the clinical trials which were conducted it was found out that those patients who were administered drug along with chemotherapy suffered fewer relapses as compared to those who were only subjected to standard chemotherapy. This medicine is aimed at those patients in whose case the breast tumors produce significant amount of protein called HER-2 and world over every year 250,000 are detected with HER-2 positive. Herceptin got the approval in 1998 for treating breast cancer after it reached out to other parts of the body and this expanded approval is aimed at patients whose breast or lymph node has been removed surgically.